What is Global Cell Therapy Market?
The Global Cell Therapy Market is a vast and rapidly evolving sector that plays a crucial role in the medical field. It involves the administration of live, whole cells or maturation of a specific cell population in a patient for the treatment of a disease. The market has seen significant growth in recent years, driven by advancements in technology and an increased understanding of the human body at a cellular level. The value of this market was estimated to be around US$ 101000 million in 2023, and it's projected to reach a staggering US$ 250460 million by 2030. This growth trajectory, representing a CAGR of 13.5% during the forecast period 2024-2030, is a testament to the increasing acceptance and application of cell therapies worldwide.
Stem Cell, Non-Stem Cell in the Global Cell Therapy Market:
The Global Cell Therapy Market is segmented into two main categories: Stem Cell and Non-Stem Cell therapies. Stem Cell therapies involve the use of stem cells, which are unique cells capable of self-renewal and differentiation into various cell types. These therapies have shown promise in treating a range of conditions, from cancer to neurodegenerative diseases. On the other hand, Non-Stem Cell therapies involve the use of other types of cells, such as immune cells, to treat diseases. Both these segments have their unique advantages and challenges, and their development and growth are influenced by various factors, including technological advancements, regulatory policies, and market demand.
Hospital, Clinic in the Global Cell Therapy Market:
The Global Cell Therapy Market finds its applications in various healthcare settings, primarily in hospitals and clinics. Hospitals are the largest consumers of cell therapies, accounting for about 77.2% of the market in 2019. This can be attributed to the fact that most cell therapies require sophisticated infrastructure and skilled personnel for administration, which are readily available in hospital settings. Clinics, on the other hand, also utilize cell therapies, especially for outpatient procedures and follow-up treatments. The use of cell therapies in these settings is expected to increase in the future, driven by advancements in cell therapy technologies and increasing patient demand.
Global Cell Therapy Market Outlook:
In 2019, the Global Cell Therapy Market was valued at US$ 101000 million. It is projected to reach a value of US$ 250460 million by 2030, growing at a CAGR of 13.5% during the forecast period of 2024 to 2030. The majority of cell therapy applications are found in hospitals, which accounted for approximately 77.2% of the market in 2019. North America is the largest consumer of cell therapies, holding a market share of nearly 43.65% in 2019. This dominance can be attributed to the region's advanced healthcare infrastructure, high investment in research and development, and the presence of key market players.
| Report Metric | Details |
| Report Name | Cell Therapy Market |
| Accounted market size in 2023 | US$ 101000 million |
| Forecasted market size in 2030 | US$ 250460 million |
| CAGR | 13.5% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
